Kazia Therapeutics (KZIA) Net Margin (2011 - 2017)
Kazia Therapeutics (KZIA) posted Net Margin of 123.34% for Q2 2017, down 20.05% on a QoQ basis from 102.74% in Q4 2016, and up 17523.0% year-over-year from N/an in Q2 2016.
Kazia Therapeutics (KZIA) Net Margin (2011 - 2017) Analysis & Trends
Kazia Therapeutics' Net Margin history runs 6 years deep, the most recent figure standing at 123.34% for Q2 2017.
- Quarterly Net Margin rose 17523.0% year-over-year to 123.34% in Q2 2017, while the trailing twelve-month figure through Jun 2017 was 173.71% (up 5361.0% YoY) and the FY2025 annual result came in at 49290.48%, down 4814165.0% from the prior year.
- Net Margin was 123.34% for Q2 2017 at Kazia Therapeutics, down from 102.74% in the prior quarter.
- Across five years, Net Margin topped out at 102.74% in Q4 2016 and bottomed at 190353773.13% in Q4 2013.
- A 4-year average of 38070910.97% and a median of 257.07% in 2015 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2013 — Net Margin slumped 2000000000 bps — and 2017, when it jumped 17523 bps.
- Kazia Therapeutics' Net Margin stood at 190353773.13% in 2013, then jumped by 100 bps to 257.07% in 2015, then jumped by 60 bps to 102.74% in 2016, then retreated by 20 bps to 123.34% in 2017.
- Business Quant data shows KZIA's Net Margin at 123.34% in Q2 2017, 102.74% in Q4 2016, and 298.58% in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -123.34% |
| Dec 31, 2016 | -102.74% |
| Jun 30, 2016 | -298.58% |
| Dec 31, 2015 | -257.07% |
| Dec 31, 2013 | -190,353,773.13% |
| Dec 31, 2012 | -61.99% |
| Dec 31, 2011 | 1,187.37% |